From Lab to Launch: Modernizing ERP for Agile Life Sciences Growth

Life sciences organizations are under pressure to scale rapidly without compromising compliance, data integrity, or the pace of innovation. As biotech and emerging pharma companies move toward IND or BLA milestones and eventual commercialization, disconnected systems across finance, supply chain, quality, and clinical operations can create audit risk, limit visibility, and slow decision-making. The challenge is knowing when spreadsheets and point solutions have reached their limits, and when ERP investment becomes critical to the next stage of growth.
Leading organizations are building scalable ERP foundations earlier, connecting critical functions through a trusted system of record while preparing for increased regulatory and operational complexity. Cloud ERP can provide the visibility, controls, and flexibility needed to strengthen GxP compliance and audit readiness, support FDA data integrity requirements, and scale operations without repeatedly rebuilding technology as the business evolves.

Join Accenture Edge and a select group of your peers in Boston to explore how life sciences leaders are moving from lab to launch with an ERP strategy built for growth. Executives will discuss how to identify the right time to modernize ERP, connect data and operations across the enterprise, and build a scalable foundation that supports regulatory readiness, investor expectations, and commercialization, without slowing innovation.

Accenture Edge helps mid-market companies with annual revenues between $300 million and $3 billion, harness AI, and reinvent how they operate. Backed by Accenture's large-enterprise expertise and deep ecosystem partnerships, Accenture Edge delivers pre-built, right-sized solutions that help mid-market organizations modernize core systems, adopt AI, strengthen security, and simplify operations at speed and scale. Learn more at www.accenture.com/edge.